We have previously reported that ursolic acid, a pentacyclic triterpene acid, inhibited the invasion of HT1080 human ®brosarcoma cells by reducing the expression of matrix metalloproteinase-9. Since the chemical structure of ursolic acid is very similar to that of dexamethasone, a synthetic glucocorticoid, we investigated whether ursolic acid acts through the glucocorticoid receptor. The expression of matrix metalloproteinase-9 is thought to be regulated similarly with matrix metalloproteinase-1 and matrix metalloproteinase-3 as containing common 2-O-tetradecanoylphorbol-acetate responsible region, where AP-1 proteins can bind. Dexamethasone has been studied to repress the 2-O-tetradecanoylphorbolacetate-induced expression of matrix metalloproteinase-1 and matrix metalloproteinase-3 through a glucocorticoid receptor-mediated manner. In Northern blot analysis, we found that ursolic acid reduced the expression of matrix metalloproteinase-1 and matrix metalloproteinase-3 induced by 2-O-tetradecanoylphorbol-acetate. Similarly, ursolic acid down-regulated 2-O-tetradecanoylphorbolacetate-induction of matrix metalloproteinase-9 gene in the same manner of dexamethasone. RU486, a potent glucocorticoid receptor antagonist, was used for identifying that ursolic acid-induced down-regulation of matrix metalloproteinase-9 expression is mediated by its binding to glucocorticoid receptor. The eect of ursolic acid on the matrix metalloproteinase-9 expression was blocked by RU486, suggesting that ursolic acid acts via a glucocorticoid receptor in the regulation of matrix metalloproteinase-9. Western blot analysis and immunocytochemistry showed that ursolic acid increased glucocorticoid receptor fraction in the nucleus, although it decreased the synthesis of glucocorticoid receptor mRNA. In addition, ursolic acid did not decrease the expression of c-jun and DNAbinding activity of AP-1 to its cognate sequences. Taken together, we suggest that ursolic acid may induce the repression of matrix metalloproteinase-9 by stimulating the nuclear translocation of glucocorticoid receptor, and the translocated glucocorticoid receptor probably downmodulating the trans-activating function of AP-1 to 2-Otetradecanoylphorbol-acetate responsible element of matrix metalloproteinase-9 promoter region.
Introduction
Ursolic acid (UA), a pentacyclic triterpene acid, was isolated from many kinds of medicinal plants, such as Eriobotrya japonica, Rosmarinus ocinalis, and Glechoma hederaceae Huang et al., 1994; Tokuda et al., 1986; Ohigashi et al., 1986) . UA has been reported to produce anti-tumor activities including inhibition of skin tumorigenesis (Huang et al., 1994) , induction of tumor cell dierentiation (Lee et al., 1994) , anti-tumor promotion Ohigashi et al., 1986) , and anti-angiogenic eect in chick chorioallantoic membrane (CAM) (Sohn et al., 1995) . In addition, we previously reported that UA has the anti-invasive activity in the HT1080 human ®brosarcoma cell by reducing the expression of matrix metalloproteinase-9 (MMP-9) (Cha et al., 1996) .
The promoter region of MMP-9 was characterized as having three important cis-element. These elements are possible binding sites for Ap-1, Sp-1, and NF-kB, or related proteins. Deletion or mutation analysis revealed that these three motifs contributed positively to MMP-9 induction by 2-O-tetradecanoylphorbolacetate (TPA) or tumor necrosis factor-a (TNF-a). The AP-1 binding site on MMP-9 gene was shown to play a master role in the induction of MMP-9, cooperating synergistically with the element of the Sp-1-like and the NF-kB-like factors . The signal to the AP-1 sites is common for the genes of TPA-inducible matrix metalloproteinases such as MMP-1 and MMP-3.
Glucocorticoid hormones have been reported to be potent inhibitors of MMP-1 and MMP-3 of which expression can be induced by AP-1 stimulated by phorbol esters such as TPA (Jonat et al., 1990; Nicolson et al., 1990; SchuÈ le et al., 1990) . It has been also reported that the repression of AP-1-responsive genes which is located in a TPA responsible element (TRE) is mediated by glucocorticoid receptor (GR) through a direct interaction with c-Jun (Diamond et al., 1990; Lucibello et al., 1990; SchuÈ le et al., 1990; Touray et al., 1991; Yang-Yen et al., 1990) or c-Fos (Kerppola et al., 1993) . However, glucocorticoid does not induce protein synthesis or aect the binding activity of AP-1 to DNA. In fact, the down-modulation of the transactivating function of AP-1 by GR was suggested to be mediated through the interaction with either the preexisting unbound or DNA-bound AP-1. This suggestion was supported by coprecipitation experiments with AP-1 and GR (Jonat et al., 1990) .
In this study, we investigated whether UA reduced the expression of MMP-9 through the GR-mediated transrepression of AP-1 since UA has a chemical structure resembling that of dexamethasone (Dexa) (Sohn et al., 1995) .
Results
Down-regulation of the TPA-induced expression of MMP-1 and MMP-3 genes by UA GR-mediated transrepression of AP-1-induced genes containing TRE has been completely studied in MMP-1 and MMP-3 (Jonat et al., 1990; Nicolson et al., 1990; SchuÈ le et al., 1990) . To identify whether the action of UA is through a GR-mediated manner, we ®rst analysed the eect of UA on the expression of MMP-1 and MMP-3. Since the basal levels of MMP-1 and MMP-3 were extremely low in the HT1080 human ®brosarcoma cells, we induced the level of MMP-1 and MMP-3 by TPA. As demonstrated in Figure 1 , treatment with 10 mM of Dexa for 3 or 6 days drastically reduced TPA-induced expression of MMP-1 and MMP-3. Similarly, treatment with 5, 7.5 or 10 mM of UA for 3 or 6 days clearly revealed down-regulation of MMP-1 and MMP-3. From these results, UA clearly reduced the level of MMP-1 and MMP-3 induced by TPA and this pattern was rather milder than the result from Dexa but appeared in good accordance with each other. These data suggested that the action of UA on the transrepression of MMP-1 and MMP-3 might be through the similar mechanism to Dexa. Down-regulation of the TPA-induced expression of MMP-9 gene by UA We previously reported that UA inhibited the invasion of HT1080 cells by reducing the basal level of MMP-9 expression (Cha et al., 1996) . We further tried to investigate whether UA can also down-regulate the TPA-induced expression of MMP-9 in the similar manner to those of MMP-1 and MMP-3. Indeed, the expression of MMP-9 was highly induced by TPA and this induction of MMP-9 was reduced by the treatment with 10 mM of Dexa for 6 days about 80% (Figure 2 ). The expression of TPA-induced MMP-9 was not changed signi®cantly by the treatment of UA for 1 The data in (a) were quantitated using the Image Pro-Plus (Media Cybernetics) and adjusted to variation in 18S and 28S rRNA day but slightly changed for 3 days, while treatment with UA for 6 days reduced the level of TPA-induced MMP-9 in a concentration-dependent manner up to approximately 50%. Moreover, the eect of UA on the repression of the TPA-induced MMP-9 was con®rmed at the protein level by the gelatin-based zymography. As expected, treatment with 10 mM of UA for 6 days reduced the enzyme activity of 92 kDa collagenase (MMP-9) induced by 50%, meanwhile, Dexa downregulated the enzyme activity by about 90% in the same condition (Figure 3) . It is almost the same pattern with the result of Northern blot analysis demonstrated in Figure 2 . From the observation of gelatin-based zymography, the level of pro-MMP-2, 72 kDa latent form of type IV collagenase was reduced by TPA. However, either UA or Dexa did not change the activity of pro-MMP-2 (Figure 3a) . The activation of 72 kDa pro-MMP-2 to active form (62 kDa) was induced by TPA, which is in accordance with the previous result of Brown et al. (1990) . Interestingly, this activation was inhibited by treatment with UA or Dexa for 6 days. It shows that UA as well as Dexa probably block the action of TPA. Dierence in the ratio of 72 and 92 kDa activities in the ®rst lane between the lower and upper portions of Figure 3a was probably due to the serum containing MMP-2. Therefore, the relative activities of 72 kDa and 92 kDa can be changed according to the number of the cells and the amount of cell culture medium containing 72 kDa enzyme.
From the Northern blot analysis, we con®rmed that the mRNA level of MMP-2 was down-regulated by TPA but not changed signi®cantly by either UA or Dexa ( 
Eect of RU486 on the down-regulation of MMP-9 by UA
In order to examine the possibility that GR is involved in the down-regulation of 92 kDa MMP-9 by UA, we treated RU486, a potent GR antagonist (Alexandrova, 1992; McRae, 1994) . In the gelatin-based zymography, treatment with 10 mM of UA for 6 days reduced the basal level of 92 kDa MMP-9 by 80%, while cotreatment with 10 mM of RU486 for the same periods restored the level of MMP-9 up to approximately 70% of control level (Figure 5a and b). In Figure 5c basal level of MMP-9 up to 90% of control. RU486, therefore, clearly blocked down-regulation of MMP-9 by UA or Dexa at the protein level. These results indicate that the action of UA on the down-regulation of MMP-9 might be mediated through the GR.
UA-induced translocation of GR to the nucleus
To determine whether UA induce the translocation of GR from cytosol to nucleus like the action of Dexa, we stained HT1080 cells with anti-GR antibody after treatment with 10 mM of UA for 3 or 6 days. Figure 6a shows that the immunoreactivity of GR in the untreated cells was mainly localized in the cytoplasm whereas treatment with 10 mM of Dexa or UA for 3 days drastically promoted translocation of GR from cytosol to nucleus. However, treatment with UA or Dexa for 6 days diminished the level of translocated GR in the nucleus (data not shown). This result may be caused partly by down-regulation of GR expression by UA or Dexa as previously reported in Rosewicz et al. (1988) .
To con®rm whether UA stimulated the translocation of GR, the nuclear and cytosol extracts were prepared separately for Western blot analysis. Figure 6b indicates that the treatment with UA for 3 days increased the amount of nuclear GR by more than 1.5-fold. In contrast, co-treatment of RU486 with UA for 3 or 6 days potently inhibited the UA-induced translocation of GR to almost same level as control. It seems most likely that UA actually induced translocation of GR into nucleus, which is blocked by the GR antagonist, RU486. Treatment with UA alone or in combination with RU486 for 6 days reduced the level of GR in the nucleus to same level as control and to about 0.8-fold of control, respectively. It seems to be resulted from the down-regulation of GR by UA as referred above. However, we could not detect the dierence of the GR level in the cytosolic fraction between UA-treated and untreated cells by Western blot suggesting that the level of GR in the cytosol was much higher compared to that of GR in the nucleus (data not shown).
Eect of UA on the expression of c-jun and GR As shown in above results, UA induced the translocation of GR from the cytosol to the nucleus and may interfere the action of AP-1 for the expression of MMP-9. In addition, we examined whether UA modulates the expression of c-jun, a major component of AP-1 or GR. The mRNA levels of c-jun and GR were analysed by Northern blot analysis after treatment with UA or Dexa. As shown in Figure 7 , the expression of c-jun was moderately increased by UA or Dexa. The induction of c-jun by Dexa was previously reported by Jonat et al. (1990) . This increase may be due to a feedback mechanism against the action of Dexa or UA. The treatment with 10 mM of Dexa for 1, 3 or 6 days reduced the mRNA level of GR, which is consistent with the data previously reported by Rosewicz et al. (1988) . Treatment with 10 mM of UA for 6 days signi®cantly reduced the expression of GR although it is milder than the eect of Dexa (Figure 7) .
Eect of UA on the binding of AP-1 to AP-1 binding site on TRE
We conducted a gel retardation assay to measure the interaction between AP-1 and its speci®c DNA recognition sequences. Following incubation of the nuclear extracts with a radiolabeled double-stranded recognition sequences, the bound oligonucleotide was detected by its mobility retardation in a nondenaturing gel. As shown in Figure 8 , nuclear extracts containing the translocated GR in response to Dexa or UA showed no signi®cant reduction in binding Jonat et al. (1990) . These data may be related to the induction of c-jun by UA or Dexa. Therefore, this result suggested that UA-mediated repression of MMP-9 was not mediated through the alteration of binding activity of AP-1 to the cognate sequences on the TRE.
Discussion
It has been previously reported that UA has an inhibitory eect on the invasive activity of the HT1080 cells in a concentration dependent manner (Cha et al., 1996) . Invasion of the basement membrane by tumor cells is mediated through many proteolytic enzymes including MMPs (Liotta et al., 1979 (Liotta et al., , 1980 Templeton et al., 1990; Wilhelm et al., 1989; Frederick, 1991) . In fact, MMPs have been reported to play a key role in the invasion of tumor cells. We recently demonstrated that the inhibitory eect of UA on tumor cell invasion is partially attributable to the down-regulation of the expression of MMP-9 (Cha et al., 1996) . Since the chemical structure of UA resembles that of Dexa, a synthetic glucocorticoid, we assumed that UA might act as a glucocorticoid through the GR-mediated manner. There have been several mechanisms by which GR-mediated transrepression. These include that GR binds to sequences overlapping a cis-acting element for another trans-acting factor, thereby displaces it from, or prevents its binding to the cognate element (Akerblom et al., 1988; Drouin et al., 1989; Oro et al., 1988; StroÈ mstedt et al., 1991) . GR-mediated transrepression has also been attributed to the direct or indirect interaction of the GR with other transacting factors, resulting in inhibition of their activity and/or ability to bind to DNA (Celada et al., 1993; Diamond et al., 1990; Gauthier et al., 1993; Jonat et al., 1990; Kutoh et al., 1992; Lucibello et al., 1990; Ray and Prefontaine, 1994; SchuÈ le et al., 1990; Tverberg and Russo, 1992; Yang-Yen et al., 1990 ). In these model systems, it is necessary that at ®rst, ligand binds with its receptor to stimulate receptor activation, and next, the activated receptor complex be dissociated from hsp90, and then nuclear translocation be occurred. However, the recent report showed that GR-dependent transrepression of AP-1 was ligandindependent, which was observed in transfected cells after heat shock in the absence of ligand (Liu et al., 1995) . In particular, the action mechanism of glucocorticoid hormone to inhibit the transcription of collagenases has been suggested by nuclear translocation of GR and its interfering the AP-1, the main After treatment with 10 mM of UA, 10 mM of Dexa or 10 mM of RU486 for 3 or 6 days, the cells were harvested and nuclear proteins (20 mg) were fractionated and transferred to Hybond-ECL. The ®lters were blotted with anti-GR antibody and detected by ECL and the data were quantitated using the Image-Pro Plus transcriptional activator of collagenases. Dexa activates and translocates GR from cytosol to nucleus by dissociating it from hsp90. The translocated GR inhibits the activity of AP-1 by directly binding to it (Jonat et al., 1990; Nicolson et al., 1990; SchuÈ le et al., 1990; Liu et al., 1995) . MMP-9 has the AP-1 binding sequences on the promoter region . Therefore, the decreased expression of MMP-9 by UA could be due to the reduced transactivation activity of AP-1 through the interaction with nuclear GR. Indeed, the TPAinduced MMP-1 and MMP-3 were signi®cantly reduced by Dexa or UA as illustrated in Figure 1 . Similarly, Dexa or UA reduced the TPA-induced MMP-9 gene expression (Figure 2) . However, TPAinduced MMP-9 was regulated by a rather complicated manner through three major regulatory elements such as NF-kB, Sp-1 binding sites and TRE region . Indeed, it was previously reported that NFkB and Sp-1 sites are required for TPA-induction of MMP-9 expression . Furthermore, it was reported that TPA is actually involved in the activation of NF-kB (Hirano et al., 1995) and inhibitor of NF-kB blocks the action of TPA (Li et al., 1997) . As shown in Figure 2 , UA or Dexa can not completely inhibit the induced expression of MMP-9 by TPA because their major inhibition site is TRE region. Therefore, the eect of UA on MMP-9 is rather milder than those of MMP-1 and MMP-3.
The eects of Dexa and UA on the TPA-induced MMP-9 expression were con®rmed by the gelatin-based zymography (Figure 3 ). In addition, Figure 5 showed that the eect of UA on the reduction of MMP-9 was inhibited by RU486, a potent antagonist of glucocorticoid. These results highly indicate that UA may respond through the GR. Furthermore, the immunocytochemical analysis demonstrated that treatment with UA for 3 days drastically induced the nuclear translocation of GR and it was con®rmed by Western blot analysis of the nuclear and cytosolic fractions, respectively (Figure 6 ). Previously, we reported that glucocorticoid responsible element (GRE) binding activity was increased by UA in F9 teratocarcinoma cells (Lee et al., 1994) . It will be another interesting project to further study about UAmediated transcriptional activation of some target genes, which are activated by GR. UA actually triggered the nuclear translocation of GR, however, the amount of GR in the nucleus was reduced to the same level as control in HT1080 cells treated with UA for 6 days. This reduction may be resulted partly by down-regulation of GR expression by UA as shown in the Figure 7 . Thus, we suggest that treatment with UA for 3 days triggered the nuclear translocation of GR maximally and this induction of GR in the nucleus resulted the down-regulation of MMP-9 in HT1080 cells treated with UA for 6 days. However, the level of c-jun, which is the main component of AP-1 was increased by UA or Dexa (Figure 7) . Dexa was previously reported to increase the expression of c-jun and it suggested that UA may act with similar manner to Dexa. In addition, the translocated GR did not inhibit but stimulate the binding activity of AP-1 to the cognate binding site on the TRE in the gel retardation assay (Figure 8 ). These data suggested the induction of c-jun may result in an increase of AP-1 binding and it is consistent with the result of Jonat et al. (1990) .
Taken together, we suggest that UA may reduce the expression of MMP-9 gene by inhibiting the AP-1 activity through the stimulation of the nuclear translocation of GR.
Materials and methods

Cells and treatment of chemicals
HT1080 human ®brosarcoma cells were maintained in DMEM (Gibco) supplemented with 10% fetal bovine serum, 100 munit/ml penicillin, and 100 munit/ml streptomycin and incubated at 378C in a humidi®ed atmosphere containing 5% CO 2 in air. Cells were treated with 10 mM of UA (Sigma Chemical Co., St. Louis), dexamethasone (Sigma Chemical Co., St. Louis), and RU486 for 1, 3 and or 6 days which was kindly provided by Roussel, UCLAF (France). When the cells were treated with TPA, 20 ng/ml of TPA was added for 1 day before harvesting cells.
RNA extraction and Northern blot analysis
Total cellular RNA was prepared from HT1080 cells according to the acid-guanidine thiocyanate-phenol-chloroform extraction method (Chomczynski and Sacchi, 1987) . The RNA samples were resolved on 1% agaroseformaldehyde gels under denaturing conditions and transferred to nylon membranes (Zeta-Probe membrane, Bio-Rad). The RNA was hybridized to 32 P-dCTP-labeled cDNA probes of MMP-2, MMP-9, MT-MMP, TIMP-1 and TIMP-2 (Sato et al., 1992; Takino et al., 1995) . The ®lter was prehybridized at 428C for 4 h in a polyethylene bag with hybridization buer containing 50% deionized formamide, 7% SDS 0.12 M NaHPO 4 , and 0.25 M NaCl and then hybridized at 428C overnight in hybridization buer with denatured labeled probes. After hybridization, the ®lter was washed at 428C in 26SSC, 0.1% SDS for 15 min and 0.56SSC, 0.1% SDS for 15 min. The ®lter was then exposed to X-ray ®lm for 1 day. Quantitation of bands was routinely performed with Image-Pro Plus (Media Cybernetics, Inc., Silver Spring, MA).
Gelatin zymography
The conditioned media of 10 4 cells were analysed by the gelatin-based zymography, using the slightly modi®ed procedure of Herron et al. (1986) . Conditioned media were separated by SDS ± PAGE using 10% acrylamide copolymerized with gelatin (0.33 mg/ml). After electrophoresis, the gel was rinsed twice with 2.5% Triton X-100 for 15 min and incubated for 18 h at 378C in incubation buer (0.05 M Tris-HCl (pH 7.5), 0.15 M NaCl, 0.01 M CaCl 2 , 1 mM ZnCl 2 , 0.02% NaN 3 ). Gelatinase was identi®ed following staining of the gel in 0.25% Coomassie blue R250 and destaining with 7% acetic acid. The digested area appeared clear on a blue background indicating the location of gelatinase. Zymogram activity was measured by quanti®cation of bands with Image-Pro Plus.
Immunocytochemistry
Immunocytochemistry was conducted as the method of Ylikomi et al. (1992) . HT1080 cells grown on the coverslip were washed with PBS and incubated in 4% paraformaldehyde for 30 min at room temperature (RT) and washed in PBS. To ensure the entry of antibodies, cells were permeabilized by incubating in 0.5% Triton X-100 for 20 min at RT. After washing with PBS, cells were incubated for 20 min in blocking solution to saturate non-speci®c sites, followed by incubation with speci®c GR antibodies for 1 h at RT. After washing with PBS, speci®cally bound antibodies were detected with biotinylated secondary antibody. After 1 h incubation at RT, cells were washed with PBS and incubated with streptavidinperoxidase for 30 min at RT. Peroxidase staining was visualized using AEC chromogen as a substrate (DAKO LSAB kit). The immunoperoxidase stained samples were photographed using a phase-contrast microscope (Olympus BX 40).
Western blot analysis
Proteins were separated on 15% non-reducing PAGE (Towin et al., 1979) . After transfer, nitrocellulose membrane were washed in TBS-T solution (20 mM TrisHCl buer, pH 7.6, containing 137 mM NaCl, 1% Tween 20). They were incubated in blocking buer (5 ± 10% skim milk in TBS-T) for 12 h at 48C. The ®lter was incubated with ®rst antibody for 12 h at 48C, and then washed three times with TBS-T. After washing, the ®lter was incubated with the second antibody. The band was detected with enhanced chemiluminescence (ECL) reagents according to the supplier's protocol. The quantitation of bands were performed by Image-Pro Plus.
Gel retardation assay
Nuclear extracts were prepared from the slightly modi®ed method of Dignam et al. (1983) . The cells were harvested, resuspended in 100 ml of lysis buer (10 mM Tris-HCl (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 0.1% NP40, and 0.5 mM PMSF) and then incubated for 15 min at 08C. The mixtures were centrifuged at 13 000 g for 10 min at 08C. Nuclei pellet was resuspended in 30 ml of extraction buer (20 mM Tris-HCl (pH 7.9), 1.5 mM MgCl 2 , 0.5 mM (DTT), 25% glycerol, 0.42 M NaCl, 0.2 mM EDTA, and 0.5 mM phenylmethylsulfonyl¯uoride (PMSF)) and mixed brie¯y on a vortex. After standing for 15 min at 08C, the mixture was centrifuged for 10 min at 48C and the supernatant was transferred to a fresh tube. The extracts were diluted with 70 ml of 20 mM Tris-HCl (pH 7.9), 50 mM KCl, 0.5 mM DTT, 20% glycerol, 0.2 mM EDTA, and 0.5 mM PMSF. Protein concentration was determined by using a BCA Protein Assay Kit (Sigma).
The gel retardation assay was conducted through the methods of Adcock et al. (1995) and Guo et al. (1995) . The double-stranded oligonucleotides for the AP-1 (Promega) were 5'-end labeled with [a-32 P]ATP using T4 polyncleotide kinase and puri®ed by ethanol precipitation. Binding reactions were carried out in the buer containing 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.5 mM DTT, 10 mM MgCl 2 , 10% glycerol, 0.05% NP40, 2 mg of poly (dI-dC). Nuclear extracts of HT1080 cells were incubated with radiolabeled oligonucleotide (*5 fmol, 10 000 c.p.m.) for 20 min at 258C.
